Clinical phenotypes and outcomes associated with SARS-CoV-2 variant Omicron in critically ill French patients with COVID-19.
Journal
Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555
Informations de publication
Date de publication:
12 10 2022
12 10 2022
Historique:
received:
14
07
2022
accepted:
29
09
2022
entrez:
12
10
2022
pubmed:
13
10
2022
medline:
15
10
2022
Statut:
epublish
Résumé
Infection with SARS-CoV-2 variant Omicron is considered to be less severe than infection with variant Delta, with rarer occurrence of severe disease requiring intensive care. Little information is available on comorbid factors, clinical conditions and specific viral mutational patterns associated with the severity of variant Omicron infection. In this multicenter prospective cohort study, patients consecutively admitted for severe COVID-19 in 20 intensive care units in France between December 7th 2021 and May 1st 2022 were included. Among 259 patients, we show that the clinical phenotype of patients infected with variant Omicron (n = 148) is different from that in those infected with variant Delta (n = 111). We observe no significant relationship between Delta and Omicron variant lineages/sublineages and 28-day mortality (adjusted odds ratio [95% confidence interval] = 0.68 [0.35-1.32]; p = 0.253). Among Omicron-infected patients, 43.2% are immunocompromised, most of whom have received two doses of vaccine or more (85.9%) but display a poor humoral response to vaccination. The mortality rate of immunocompromised patients infected with variant Omicron is significantly higher than that of non-immunocompromised patients (46.9% vs 26.2%; p = 0.009). In patients infected with variant Omicron, there is no association between specific sublineages (BA.1/BA.1.1 (n = 109) and BA.2 (n = 21)) or any viral genome polymorphisms/mutational profile and 28-day mortality.
Identifiants
pubmed: 36224216
doi: 10.1038/s41467-022-33801-z
pii: 10.1038/s41467-022-33801-z
pmc: PMC9555693
doi:
Types de publication
Journal Article
Multicenter Study
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
6025Commentaires et corrections
Type : ErratumIn
Informations de copyright
© 2022. The Author(s).
Références
Bouzid, D. et al. Comparison of patients infected with delta versus omicron COVID-19 variants presenting to paris emergency departments: a retrospective cohort study. Ann. Intern. Med. M22-0308 https://doi.org/10.7326/M22-0308 (2022).
Wolter, N. et al. Early assessment of the clinical severity of the SARS-CoV-2 omicron variant in South Africa: a data linkage study. Lancet 399, 437–446 (2022).
doi: 10.1016/S0140-6736(22)00017-4
Ledford, H. How severe are Omicron infections? Nature 600, 577–578 (2021).
doi: 10.1038/d41586-021-03794-8
Menni, C. et al. Symptom prevalence, duration, and risk of hospital admission in individuals infected with SARS-CoV-2 during periods of omicron and delta variant dominance: a prospective observational study from the ZOE COVID Study. Lancet S0140673622003270. https://doi.org/10.1016/S0140-6736(22)00327-0 (2022).
Vieillard-Baron, A. et al. Omicron variant in the critical care units of paris metropolitan area the reality research group. Am. J. Respir. Crit. Care Med. https://doi.org/10.1164/rccm.202202-0411LE (2022).
Viana, R. et al. Rapid epidemic expansion of the SARS-CoV-2 Omicron variant in southern Africa. Nature 603, 679–686 (2022).
doi: 10.1038/s41586-022-04411-y
Xia, S., Wang, L., Zhu, Y., Lu, L. & Jiang, S. Origin, virological features, immune evasion and intervention of SARS-CoV-2 Omicron sublineages. Sig. Transduct. Target Ther. 7, 1–7 (2022).
doi: 10.1038/s41392-022-01105-9
Majumdar, P. & Niyogi, S. ORF3a mutation associated with higher mortality rate in SARS-CoV-2 infection. Epidemiol. Infect. 148, e262 (2020).
doi: 10.1017/S0950268820002599
Nagy, Á., Pongor, S. & Győrffy, B. Different mutations in SARS-CoV-2 associate with severe and mild outcome. Int J. Antimicrob. Agents 57, 106272 (2021).
doi: 10.1016/j.ijantimicag.2020.106272
Pang, X. et al. Emerging severe acute respiratory syndrome coronavirus 2 mutation hotspots associated with clinical outcomes and transmission. Front. Microbiol. 12, 753823 (2021).
doi: 10.3389/fmicb.2021.753823
Saito, A. et al. Enhanced fusogenicity and pathogenicity of SARS-CoV-2 Delta P681R mutation. Nature 602, 300–306 (2022).
doi: 10.1038/s41586-021-04266-9
Bager, P. et al. Risk of hospitalisation associated with infection with SARS-CoV-2 omicron variant versus delta variant in Denmark: an observational cohort study. Lancet Infect. Dis. S1473-3099(22)00154–2 (2022).
Lewnard, J. A. et al. Clinical outcomes associated with SARS-CoV-2 Omicron (B.1.1.529) variant and BA.1/BA.1.1 or BA.2 subvariant infection in southern California. Nat. Med. https://doi.org/10.1038/s41591-022-01887-z (2022).
Robinson, M. L. et al. Impact of SARS-CoV-2 variants on inpatient clinical outcome. medRxiv 2022.02.02.22270337 https://doi.org/10.1101/2022.02.02.22270337 (2022).
RECOVERY Collaborative Group. Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. Lancet 399, 665–676 (2022).
doi: 10.1016/S0140-6736(22)00163-5
Tegally, H. et al. Emergence of SARS-CoV-2 omicron lineages BA.4 and BA.5 in South Africa. Nat. Med. 1–6 https://doi.org/10.1038/s41591-022-01911-2 (2022).
Mahase, E. Covid-19: What we know about the BA.4 and BA.5 omicron variants. BMJ 378, o1969 (2022).
doi: 10.1136/bmj.o1969
Rockwood, K. et al. A global clinical measure of fitness and frailty in elderly people. CMAJ 173, 489–495 (2005).
doi: 10.1503/cmaj.050051
WHO Working Group on the Clinical Characterisation and Management of COVID-19 infection. A minimal common outcome measure set for COVID-19 clinical research. Lancet Infect. Dis. 20, e192–e197 (2020).
doi: 10.1016/S1473-3099(20)30483-7
Vincent, J. L. et al. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med. 22, 707–710 (1996).
doi: 10.1007/BF01709751
Le Gall, J. R., Lemeshow, S. & Saulnier, F. A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study. JAMA 270, 2957–2963 (1993).
doi: 10.1001/jama.1993.03510240069035
ARDS Definition Task Force. et al. Acute respiratory distress syndrome: the Berlin Definition. JAMA 307, 2526–2533 (2012).
Kohonen, T. & Somervuo, P. How to make large self-organizing maps for nonvectorial data. Neural Netw. 15, 945–952 (2002).
doi: 10.1016/S0893-6080(02)00069-2
Gao, S., Mutter, S., Casey, A. & Mäkinen, V.-P. Numero: a statistical framework to define multivariable subgroups in complex population-based datasets. Int. J. Epidemiol. 48, 369–374 (2019).
doi: 10.1093/ije/dyy113
Chavent, M., Kuentz-Simonet, V., Labenne, A. & Saracco, J. Multivariate Analysis of Mixed Data: The R Package PCAmixdata. at http://arxiv.org/abs/1411.4911 (2017).
van de Velden, M., Iodice D’Enza, A. & Markos, A. Distance-based clustering of mixed data. WIREs Computational Stat. 11, e1456 (2019).